Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:JNJ
Johnson & Johnson
|
149.56 | 0% | 0% | 356,431.01 | 3.33% | 3.91% |
|
NYSE:MRK
Merck
|
126.88 | -6.17% | 7.56% | 318,604.29 | 2.43% | -20.48% |
|
LSE:AZN
AstraZeneca PLC
|
112.68 | 31.55% | 56.71% | 169,688.29 | 2.02% | 15.59% |
|
NYSE:PFE
Pfizer
|
26.32 | 19.53% | 52.98% | 147,226.07 | 6.4% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
88.85 | 22.24% | 41.76% | 108,487.17 | 4.26% | 8.33% |
|
LSE:GSK
GSK
|
16.51 | 19.26% | 36.94% | 65,336.14 | 3.54% | 0.4% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4122.00 | 0% | 0% | 6,383,951.56 | 4.55% | 0% |
|
SWX:LONN
Lonza Group
|
526.40 | -24.76% | -8.92% | 36,260.22 | 0.79% | 0.68% |
|
NasdaqGS:MRNA
Moderna
|
107.89 | -,114.04% | -,109.69% | 38,827.82 | 0% | 0% |
|
ENXTPA:VLA
Valneva
|
3.72 | 0% | 0% | 528.64 | 0% | 0% |
|
NasdaqGS:NVAX
Novavax
|
4.19 | 0% | 0% | 555.61 | 0% | 0% |
|
NasdaqGM:CVAC
CureVac N.V.
|
2.60 | 0% | 0% | 546.37 | 0% | 0% |
|
NasdaqCM:VBIV
VBI Vaccines
|
0.61 | 0% | 0% | 18.02 | 0% | 0% |
